Tavros is an Integrated high-throughput genomics platform to discover next generation cancer therapies .
Location: United States, North Carolina, Durham
Total raised: $7.5M
Investors 1
| Date | Name | Website |
| - | KdT Ventur... | kdtvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.09.2022 | Seed | $7.5M | KdT Ventur... |
Mentions in press and media 2
| Date | Title | Description |
| 12.10.2022 | ‘Pluck those diamonds’: Bayer’s Vividion eyes up to nine oncology targets from Duke spinout | After snapping up Vividion before it could jump onto Nasdaq last August, Bayer’s preclinical ‘arms-length’ subsidiary is betting on a relatively unknown North Carolina upstart in a five-year pact. The initial focus co... |
| 28.09.2022 | Tavros Therapeutics Raises $7.5M in Seed II Funding Round | Tavros Therapeutics, a Durham, N.C-based precision oncology platform company, raised $7.5M in Seed II funding. The round was co-led by Piedmont Capital Investments and KdT Ventures, with participation from Alexandria Venture Investments. Th... |